Literature DB >> 23733421

Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells.

Ning Song1, Yan Wang, Xiao-dong Gu, Zong-you Chen, Liu-bin Shi.   

Abstract

Eukaryotic initiation factor subunit c (eIF3c) has been identified as an oncogene that is over-expressed in tumor cells and, therefore, is a potential therapeutic target for gene-based cancer treatment. This study was focused on investigating the effect of small interfering RNA (siRNA)-mediated eIF3c gene knockdown on colon cancer cell survival. The eIF3c gene was observed to be highly expressed in colon cancer cell models. The expression levels of the gene in eIF3c siRNA infected and control siRNA infected cells were compared via real-time polymerase chain reaction (PCR) and western blotting analysis. Cell proliferation levels were analyzed employing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and colony formation assays. Furthermore, the effects of eIF3c gene knockdown on the cell cycle and apoptosis were analyzed using flow cytometry. The results showed that suppression of eIF3c expression significantly (P<0.001) reduced cell proliferation and colony formation of RKO colon cancer cells. The cell cycle was arrested by decreasing the number of cells entering S phase. Further, apoptosis was induced as a result of eIF3c knockdown. Collectively, eIF3c deletion effectively reduced the survival of colon cancer cells and could be used as a therapeutic tool for colon cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23733421      PMCID: PMC3682160          DOI: 10.1631/jzus.B1200230

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  14 in total

Review 1.  Double-stranded RNA as a template for gene silencing.

Authors:  B L Bass
Journal:  Cell       Date:  2000-04-28       Impact factor: 41.582

Review 2.  Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.

Authors:  Daniel B Longley; Wendy L Allen; Patrick G Johnston
Journal:  Biochim Biophys Acta       Date:  2006-08-09

3.  Prognostic significance of miR-215 in colon cancer.

Authors:  Mihriban Karaayvaz; Timothy Pal; Bo Song; Cecilia Zhang; Penelope Georgakopoulos; Saira Mehmood; Stephanie Burke; Kenneth Shroyer; Jingfang Ju
Journal:  Clin Colorectal Cancer       Date:  2011-07-12       Impact factor: 4.481

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

Authors:  Udit N Verma; Rama M Surabhi; Aurelia Schmaltieg; Carlos Becerra; Richard B Gaynor
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

6.  A transient three-plasmid expression system for the production of high titer retroviral vectors.

Authors:  Y Soneoka; P M Cannon; E E Ramsdale; J C Griffiths; G Romano; S M Kingsman; A J Kingsman
Journal:  Nucleic Acids Res       Date:  1995-02-25       Impact factor: 16.971

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.

Authors:  N J Caplen; S Parrish; F Imani; A Fire; R A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 9.  siRNA-based approaches in cancer therapy.

Authors:  G R Devi
Journal:  Cancer Gene Ther       Date:  2006-01-20       Impact factor: 5.987

10.  Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).

Authors:  Daniel R Scoles; William H Yong; Yun Qin; Kolja Wawrowsky; Stefan Matthias Pulst
Journal:  Hum Mol Genet       Date:  2006-02-23       Impact factor: 6.150

View more
  11 in total

1.  Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells.

Authors:  Jinmin Hao; Chaohui Liang; Baohua Jiao
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

Review 2.  eIF3: a factor for human health and disease.

Authors:  Andreia Gomes-Duarte; Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  RNA Biol       Date:  2017-11-13       Impact factor: 4.652

Review 3.  Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target.

Authors:  Maomao Wu; Yanxun Han; Xiangfei Gong; Ke Wan; Yuchen Liu; Yi Zhou; Lizhi Zhang; Guozheng Tang; Hui Fang; Bangjie Chen; Fan Yang; Qing Zhao; Genbao Wang; Chenghao Zhanghuang; Yunling Zhang
Journal:  Front Med (Lausanne)       Date:  2022-06-23

4.  Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.

Authors:  Nicole Golob-Schwarzl; Caroline Schweiger; Carina Koller; Stefanie Krassnig; Margit Gogg-Kamerer; Nadine Gantenbein; Anna M Toeglhofer; Christina Wodlej; Helmut Bergler; Brigitte Pertschy; Stefan Uranitsch; Magdalena Holter; Amin El-Heliebi; Julia Fuchs; Andreas Punschart; Philipp Stiegler; Marlen Keil; Jens Hoffmann; David Henderson; Hans Lehrach; Christoph Reinhard; Christian Regenbrecht; Rudolf Schicho; Peter Fickert; Sigurd Lax; Johannes Haybaeck
Journal:  Oncotarget       Date:  2017-09-05

5.  Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.

Authors:  Tangjian Li; Shengli Li; Di Chen; Bing Chen; Tao Yu; Fangyu Zhao; Qifeng Wang; Ming Yao; Shenglin Huang; Zhiao Chen; Xianghuo He
Journal:  Cancer Sci       Date:  2017-04-26       Impact factor: 6.716

Review 6.  Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer-The Case for Combined Delivery?

Authors:  Rita Mendes; Alexandra R Fernandes; Pedro V Baptista
Journal:  Genes (Basel)       Date:  2017-03-02       Impact factor: 4.096

Review 7.  Role of Eukaryotic Initiation Factors during Cellular Stress and Cancer Progression.

Authors:  Divya Khandige Sharma; Kamiko Bressler; Harshil Patel; Nirujah Balasingam; Nehal Thakor
Journal:  J Nucleic Acids       Date:  2016-12-19

8.  EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma.

Authors:  Hsin-Yi Lee; Chi-Kuan Chen; Chun-Ming Ho; Szu-Shuo Lee; Chieh-Yu Chang; Kuan-Ju Chen; Yuh-Shan Jou
Journal:  Oncotarget       Date:  2018-01-11

9.  Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNK.

Authors:  Weilu Gao; Yong Hu; Zhengqin Zhang; Gongwen Du; Li Yin; Zongsheng Yin
Journal:  Onco Targets Ther       Date:  2019-02-14       Impact factor: 4.147

10.  Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells.

Authors:  Fang Wen; Zhang-Ying Wu; Lei Nie; Qi-Zhu Zhang; Yuan-Kun Qin; Zun-Lun Zhou; Jin-Jian Wu; Xing Zhao; Jun Tan; Darrell Sawmiller; Dan Zi
Journal:  Biosci Rep       Date:  2019-08-05       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.